Liver transplantation for malignancies

被引:16
作者
Eghtesad B. [1 ]
Aucejo F. [1 ]
机构
[1] Cleveland Clinic, Desk A-100, 9500 Euclid Avenue, Cleveland, 44195, OH
关键词
Liver transplantation; Primary hepatic malignancies; Secondary hepatic malignancies;
D O I
10.1007/s12029-014-9590-2
中图分类号
学科分类号
摘要
Liver transplantation (LT) has become an acceptable and effective treatment for selected patients with hepatocellular carcinoma with excellent outcomes. More recently, LT has been tried in different primary and secondary malignancies of the liver. The outcomes of LT for very selected group of patients with hilar cholangiocarcinoma (CCA) have been promising. Excellent results have been reported in LT for patients with unresectable hepatic epithelioid hemangioendothelioma (HEHE). In contrast to excellent results after LT for HEHE, results of LT for angiosarcoma have been disappointing with no long-term survivors. Hepatoblastoma (HB) is the most common primary liver cancer in pediatric age group. Long-term outcomes after LT in patients with unresectable tumor and good response to chemotherapy have been promising. Indication for LT for hepatic metastasis from neuroendocrine tumors (NETs) is mainly for patients with unresectable tumors and for palliation of medically uncontrollable symptoms. Posttransplant survival in those patients with low tumor activity index is excellent, despite recurrence of the tumor. More recent limited outcomes data on LT for unresectable hepatic metastases from colorectal cancer have claimed some survival benefit compared to the previous reports. However, due to the high rate of tumor recurrence in a very short time after LT, especially in the era of organ shortage, this indication has not been favored by the transplant community.
引用
收藏
页码:353 / 362
页数:9
相关论文
共 50 条
  • [41] Liver transplantation for acute liver failure
    Fischer, L
    Sterneck, M
    Rogiers, X
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (09) : 985 - 990
  • [42] Liver transplantation for benign liver tumors
    Ostojic, Ana
    Mrzljak, Anna
    Mikulic, Danko
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 1098 - 1106
  • [43] Liver Transplantation for Colorectal Liver Metastasis
    Jacopo Lanari
    Svein Dueland
    Pål-Dag Line
    Current Transplantation Reports, 2020, 7 : 311 - 316
  • [44] Liver Transplantation for Metabolic Liver Disease: Experience at a Living Donor Dominant Liver Transplantation Center
    Kim, Jun Suk
    Kim, Kyung Mo
    Oh, Seak Hee
    Kim, Hyun Jin
    Cho, Jin Min
    Yoo, Han-Wook
    Namgoong, Jung-Man
    Kim, Dae Yeon
    Kim, Ki-Hun
    Hwang, Shin
    Lee, Sung-Gyu
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2015, 18 (01) : 48 - 54
  • [45] HCV and Liver Transplantation
    Kaplan A.
    Brown R.S., Jr.
    Current Hepatology Reports, 2021, 20 (4) : 191 - 197
  • [46] Liver transplantation for cholangiocarcinoma
    Rosen, Charles B.
    Heimbach, Julie K.
    Gores, Gregory J.
    TRANSPLANT INTERNATIONAL, 2010, 23 (07) : 692 - 697
  • [47] Liver and intestine transplantation
    Brown, RS
    Rush, SH
    Rosen, HR
    Langnas, AN
    Klintmalm, GB
    Hanto, DW
    Punch, JD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 81 - 92
  • [48] Liver transplantation in Germany
    Wolff, M
    Kalff, JC
    Schwarz, NT
    Lauschke, H
    Minor, T
    Tolba, RH
    Hirner, A
    ZENTRALBLATT FUR CHIRURGIE, 2003, 128 (10): : 831 - 841
  • [49] Sarcopenia in Liver Transplantation
    Montgomery, John
    Englesbe, Michael
    CURRENT TRANSPLANTATION REPORTS, 2019, 6 (01) : 7 - 15
  • [50] Everolimus in liver transplantation
    Trotter, James F.
    Lizardo-Sanchez, Luis
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2014, 19 (06) : 578 - 582